share_log
Breakings ·  May 23 17:30
Degron Therapeutics Announces Exclusive License Agreement With Takeda to Discover Molecular Glue Degraders
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment